RYBP expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.92949997382897E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.04150000021808E-07 |
Normal-vs-Stage2 |
2.29579999999618E-05 |
Normal-vs-Stage3 |
4.85900000235517E-08 |
Normal-vs-Stage4 |
9.54239998129935E-09 |
Stage1-vs-Stage2 |
5.904200E-01 |
Stage1-vs-Stage3 |
9.876300E-02 |
Stage1-vs-Stage4 |
3.872400E-02 |
Stage2-vs-Stage3 |
4.369400E-01 |
Stage2-vs-Stage4 |
2.901400E-01 |
Stage3-vs-Stage4 |
7.699400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.27269999778457E-09 |
Normal-vs-AfricanAmerican |
1.51451999998997E-05 |
Normal-vs-Asian |
9.312600E-01 |
Caucasian-vs-AfricanAmerican |
7.847400E-01 |
Caucasian-vs-Asian |
6.167600E-02 |
AfricanAmerican-vs-Asian |
8.017500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.85829995835718E-09 |
Normal-vs-Female |
3.19150000005486E-06 |
Male-vs-Female |
5.431700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.640000E-03 |
Normal-vs-Age(41-60Yrs) |
1.62210000986818E-09 |
Normal-vs-Age(61-80Yrs) |
7.34049999673303E-08 |
Normal-vs-Age(81-100Yrs) |
1.69260000015825E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.329400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.455000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.692400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.544000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.739900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.613610E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.197800E-01 |
Normal-vs-Grade 2 |
2.31179999999886E-05 |
Normal-vs-Grade 3 |
1.62558855265615E-12 |
Normal-vs-Grade 4 |
8.8409000009726E-08 |
Grade 1-vs-Grade 2 |
4.533800E-02 |
Grade 1-vs-Grade 3 |
1.404450E-02 |
Grade 1-vs-Grade 4 |
3.144300E-03 |
Grade 2-vs-Grade 3 |
3.006600E-04 |
Grade 2-vs-Grade 4 |
3.048000E-02 |
Grade 3-vs-Grade 4 |
9.461000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.07210000002789E-06 |
Normal-vs-ccB subtype |
1.50649999997032E-06 |
ccA subtype-vs-ccB subtype |
2.948200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.38729999710208E-08 |
Normal-vs-N1 |
1.458880E-03 |
N0-vs-N1 |
7.420000E-01 |
|
|